Furthermore, considering hemolysis and anemia are risk factors for cerebral vasculopathy [6,51] and enhanced hemolysis in G6PDd patients, the close monitoring of Hb levels in G6PDd/SCD patients, and particularly among pregnant women, is suggested. Here, GSTM1 is linked to anemia.